Tilisolol
Alternative Names: Daim; N 696; SelecalLatest Information Update: 29 Oct 2018
At a glance
- Originator Nisshin Pharma
- Developer FUJIFILM Toyama Chemical; Maruho; Nisshin Pharma; Toyama Chemical
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies; Isoquinolines
- Mechanism of Action Beta adrenergic receptor antagonists; Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris; Hypertension
- Discontinued Arrhythmias; Glaucoma
Most Recent Events
- 01 Jul 2008 Toyama Chemical has been acquired by FUJIFILM Holdings Corporation
- 11 Sep 2000 Discontinued-Preclinical for Glaucoma in Japan (Ophthalmic)
- 20 May 1997 No-Development-Reported for Glaucoma in Japan (Ophthalmic)